The human microbiota is associated with cardiometabolic risk across the epidemiologic transition/Experiment 27
From BugSigDB
Needs review
Subjects
- Location of subjects
- United States of America
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Hyperglycemia High blood glucose,High blood sugar,Hyperglycemia,hyperglycemia
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Non-hyperglycemia
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Hyperglycemia
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- All participants from all countries the United States of America with elevated fasting plasma glucose (hyperglycemia)
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- centered log-ratio
- Statistical test
- ANCOM
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, body mass index, sex, Confounders controlled for: "country" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.country
Signature 1
Needs review
Source: Figure S19b
Description: Specific oral bacterial exact sequences variances (ESV) are differentially abundant between hyperglycemic and non-hyperglycemic participants from the United States of America.
Abundance in Group 1: decreased abundance in Hyperglycemia
| NCBI | Quality Control | Links |
|---|---|---|
| Haemophilus |
Revision editor(s): Aleru Divine
